Davis Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Sell
6,521
-76
-1% -$26K 1.4% 21
2026
Q1
$2.32M Buy
6,597
+77
+1% +$27.4K 1.57% 16
2025
Q4
$2.13M Sell
6,520
-3
-0% -$952 1.47% 18
2025
Q3
$1.84M Buy
+6,523
New +$1.89M 1.28% 22
2025
Q1
$1.91M Buy
6,145
+215
+4% +$63.5K 1.53% 20
2024
Q4
$1.55M Buy
5,930
+90
+2% +$26.7K 1.26% 21
2024
Q3
$1.88M Buy
5,840
+49
+0.8% +$16K 1.49% 19
2024
Q2
$1.8M Buy
5,791
+61
+1% +$17.9K 1.56% 14
2024
Q1
$1.62M Buy
5,730
+81
+1% +$23.7K 1.45% 18
2023
Q4
$1.63M Buy
+5,649
New +$1.54M 1.56% 15
2020
Q2
$5K Hold
21
0.01% 210
2020
Q1
$4K Buy
+21
New +$4.59K 0.01% 211

Other funds holding AMGN

Davis Capital Management's AMGN Position: Q2 2026 in Review

Davis Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $26K and leaving 6,521 shares worth $2.36M. The position accounts for 1.4% of the portfolio, ranked #21.

Davis Capital Management first reported a position in AMGN in Q1 2020 and has held it in 12 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Davis Capital Management held 6,521 shares of Amgen worth $2.36M as of Q2 2026.
  • Davis Capital Management sold 76 Amgen shares in Q2 2026, an estimated $26K.
  • Amgen made up 1.4% of Davis Capital Management's portfolio in Q2 2026, its #21 holding.
  • Davis Capital Management first reported a position in Amgen in Q1 2020 and has held it in 12 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.